CIK 0001395937
- Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320162505
- Phone
- +1 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-04 | Huber Martin H. Jr. Director | Grant or award | +24,000 | 103,000 | ||
| 2025-05-19 | Huber Martin H. Jr. Director | Purchase | +5,000 | $8.99 | $45K | 79,000 |
| 2025-02-05 | Huber Martin H. Jr. Director | Grant or award | +25,000 | 74,000 | ||
| 2024-02-07 | Huber Martin H. Jr. Director | Grant or award | +17,000 | 49,000 | ||
| 2023-02-02 | Huber Martin H. Jr. Director | Grant or award | +16,000 | 32,000 | ||
| 2022-02-02 | Huber Martin H. Jr. Director | Grant or award | +16,000 | 16,000 | ||
| 2021-09-15 | Huber Martin H. Jr. Director | Grant or award · Stock Options (Right to buy) | +35,000 | $19.36 | $678K | 35,000 |
Page 1 of 1 · 7 trades